Outcome of patients with intracranial non-germinomatous germ cell tumors—lessons from the SIOP-CNS-GCT-96 trial-Reference-Cited by-同舟云学术

Outcome of patients with intracranial non-germinomatous germ cell tumors—lessons from the SIOP-CNS-GCT-96 trial

Published:2017-07-05 Issue:12 Volume:19 Page:1661-1672
ISSN:1522-8517
Container-title:Neuro-Oncology
language:en
Short-container-title:

Author:

Calaminus Gabriele,Frappaz Didier,Kortmann Rolf Dieter,Krefeld Barbara,Saran Frank,Pietsch Torsten,Vasiljevic Alexandre,Garre Maria Luisa,Ricardi Umberto,Mann Jillian R,Göbel Ulrich,Alapetite Claire,Murray Matthew J,Nicholson James C

Funder

Deutsche Krebshilfe

Publisher

Oxford University Press (OUP)

Subject

Cancer Research,Clinical Neurology,Oncology

Link

http://academic.oup.com/neuro-oncology/article-pdf/19/12/1661/22082790/nox122.pdf

Reference29 articles.

1. Intracranial germ-cell tumors: natural history and pathogenesis;J Neurosurg,1985

2. Intracranial germ cell tumors: analysis of the therapy study MAKEI 83/86 and changes in protocol for the follow-up study;Klin Padiatr,1989

3. Improved prognosis of intracranial germ cell tumors by intensified therapy: results of the MAKEI 89 therapy protocol;Klin Padiatr,1993

4. Improved chemotherapy in disseminated testicular cancer;J Urol,1977

5. Treatment of nongerminomatous germ-cell tumors of the pineal region;Neurosurgery,1994

Cited by 163 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Third ventricle teratoma with malignant transformation;Russian journal of neurosurgery;2024-09-07

2. Monitoring pediatric CNS non‐germinomatous germ cell tumors via cerebrospinal fluid circulating tumor DNA;Pediatric Blood & Cancer;2024-08-27

3. Molecular Developments in Parasellar Tumors and Potential Therapeutic Implications;Endocrine Reviews;2024-07-26

4. Acute toxicity of chemotherapy in central nervous system germ cell tumour patients according to age;Frontiers in Oncology;2024-07-15

5. Primary central nervous system germ cell tumors in Central America and the Caribbean Region: an AHOPCA 20-year experience;Frontiers in Oncology;2024-07-05